Candida tropicalis is a frequently isolated yeast species causing bloodstream, urinary tract and other infections particularly in patients admitted to intensive care units (ICUs) and those requiring prolonged urinary catheterization (UC) or receiving broad-spectrum antibiotics (BSA). This study investigated clinical characteristics and genetic relatedness among C. tropicalis strains isolated from patients at Al-Amiri Hospital in Kuwait. C. tropicalis strains (n = 63) isolated from blood, genito-urinary, respiratory (RT) and digestive (GIT) tracts and wound sites from 54 patients were used. All isolates were phenotypically identified and tested against six antifungal drugs by using Vitek 2 system. Molecular identification was performed by PCR amplification of rDNA. Fingerprinting was achieved by 6-loci-based multilocus sequence typing (MLST) and data were analyzed by BioNumerics software for phylogenetic relationships. Patients mean age was >65 years and >20% patients were hospitalized in ICUs. Most patients had underlying conditions that included UC, BSA, diabetes and RT/GIT abnormalities. Most candiduria cases had UC, ureteric stent or suprapubic catheters. All isolates were identified as C. tropicalis by Vitek 2 and by species-specific PCR. Sixty-two isolates were susceptible to all tested antifungal drugs. MLST identified 59 diploid sequence types (DSTs) including 54 newly-identified DSTs. C. tropicalis isolates from multiple sites of same patient usually belonged to different DSTs. Interestingly, 56 of 57 isolates from 48 patients belonged to unique genotypes. Only six isolates from six patients belonged to three DSTs (clusters), however, C. tropicalis strains in each cluster were isolated >3 months apart. Our data show diverse origins of C. tropicalis infections in Kuwait as most isolates were unique strains. There was no obvious correlation between cluster isolates with time of isolation and/or hospital ward of their origin. This study presents the first MLST analysis of C. tropicalis isolates from Middle East and may be useful for studying genetic relationships among global C. tropicalis strains.
Citation: Al-Obaid K, Asadzadeh M, Ahmad S, Khan Z (2017) Population structure and molecular genetic characterization of clinical Candida tropicalis isolates from a tertiary-care hospital in Kuwait reveal infections with unique strains. PLoS ONE 12(8): e0182292. https://doi.org/10.1371/journal.pone.0182292
Editor: Vishnu Chaturvedi, Wadsworth Center, UNITED STATES
Received: May 2, 2017; Accepted: July 15, 2017; Published: August 30, 2017
Copyright: © 2017 Al-Obaid et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The study was funded by Kuwait University Research Sector grant MI02/15 and core facility grant SRUL02/13.
Competing interests: The authors have declared that no competing interests exist.
Candida spp. are important constituent of human microbial flora of skin, mucous membranes of mouth and vagina and gastrointestinal tract. They are also opportunistic human pathogens. The infections range in severity from mild superficial infections to life-threatening bloodstream and invasive infections inflicting considerable morbidity and mortality, particularly in immunocompromised and hospitalized patients [1, 2]. Candida spp. are now the fourth most common cause of all bloodstream infections and the third most common cause of bloodstream infections in patients in the intensive care unit (ICU) in many tertiary-care hospitals across the world with an attributable mortality of 15–35% in adults and 10–15% in neonates [3–5]. Nearly 90% of invasive Candida infections are caused by only four species or species complexes which include Candida albicans, Candida glabrata, Candida parapsilosis, and Candida tropicalis [3–6]. Candida tropicalis is the second most frequently isolated Candida from bloodstream in many countries and is also the leading cause of nosocomial fungemia and invasive fungal infections in patients with hematologic and other malignancies in several countries [5–10]. C. tropicalis infections are more common in older patients admitted to ICUs and those requiring prolonged urinary catheterization (UC) or receiving broad-spectrum antibiotics (BSA) [7, 11]. Antifungal drug susceptibility testing of Candida spp. isolates have also shown that the frequency of fluconazole-resistant (including isolates that show intermediate susceptibility) C. tropicalis strains is high (~10%) and is comparable to that of C. glabrata isolates in some Asian countries [6, 12, 13].
Candiduria, Candida colonization or infection of the urinary tract, is also common among hospitalized patients with predisposing diseases such as diabetes mellitus and abnormalities of the kidney and urinary tract (urinary tract obstruction, surgery or instrumentation), especially those in the ICU as they acquire several common risk factors such as urinary drainage devices, parenteral nutrition, mechanical ventilation and broad-spectrum antibacterial therapy [11, 14]. Candida spp. are third most common organisms isolated from urine samples of hospitalized patients and age older than 65 years, female sex, diabetes mellitus and urinary tract abnormalities are independent risk factors for developing candiduria [11, 14–16]. In many tertiary care facilities, nearly 10% of all cultures from urine samples yield Candida spp. isolates with C. tropicalis as the second or third most common Candida species causing candiduria [11, 15–19]. Treatment of candiduria in patients with symptoms of urinary tract infection (UTI) is beneficial and mortality rates are higher in hospitalized patients who have candiduria compared to similar patients without candiduria [7, 11, 14, 20].
The origin of nosocomial Candida infections could be endogenous strains brought into the hospital environment by the patients themselves or exogenous strains transmitted to the patients from biomedical devices, contaminated infusates, hospital surroundings and health care workers [21, 22]. Two molecular typing techniques, capable of discriminating closely related but non-identical isolates, multilocus sequence typing (MLST) based on single-nucleotide polymorphisms within housekeeping genes with discriminatory power of 0.99 and multilocus microsatellite typing (MLMT) based on microsatellite length polymorphism with discriminatory power of 0.97 have mostly been used in recent years for determining genetic relatedness among clinical C. tropicalis isolates [23–25]. Of these, MLST is a standardized scheme based on six conserved housekeeping genes and has a publicly accessible and curated online C. tropicalis MLST database (http://pubmlst.org/ctropicalis/) for worldwide comparisons. Previous studies based on MLMT and MLST have shown that most C. tropicalis infections develop as a consequence of endogenous colonization with this species, however, outbreaks of C. tropicalis candiduria due to poor management of medical waste (urine) in ICUs have also been described [11, 26–29]. However, such studies have not been carried out from any of the Middle Eastern countries.
This study performed molecular genetic characterization of C. tropicalis strains isolated at a major tertiary-care hospital in Kuwait by MLST to ascertain nosocomial clusters/common source of infection among patients and compared MLST data with data obtained previously from a global collection of isolates to better understand the population structure of C. tropicalis.
Materials and methods
Reference strains and clinical isolates of C. tropicalis
Reference strains of C. tropicalis (ATCC 750), Candida viswanathii (CBS 1924), C. albicans (ATCC 90028), Candida dubliniensis (CD36), C. parapsilosis (ATCC 22019), Candida orthopsilosis (ATCC 96139), Candida metapsilosis (ATCC 96143), Lodderomyces elongisporus (CBS 2605), C. glabrata (ATCC 15545), Candida nivariensis (CBS 9983), Candida bracarensis (CBS 10154), Candida krusei (ATCC 6258) and Candida haemulonii (CBS 5149) were used. Fifty-seven C. tropicalis isolates obtained from 48 consecutive patients at Al-Amiri, a major tertiary-care hospital in Kuwait, during an 8-month period (March 2015 to October, 2015) were used. Additionally, six isolates collected eight months later from six patients were also used for comparison purposes. Most (54 of 63, 86%) isolates originated from genito-urinary and respiratory (RT)/gastro-intestinal (GIT) tract specimens including urine (n = 38), vaginal swab (n = 1), sputum (n = 1), endotracheal aspirate (n = 2), oral/throat swab (n = 4), tracheostomy (n = 1), percutaneous endoscopic gastrostomy (n = 4), stool/anal swab (n = 2) and abdominal fluid (n = 1). The remaining nine isolates were obtained from bloodstream (n = 5) and skin wound swabs (n = 4). Thus, a total of 63 C. tropicalis isolates from 54 patients were used. The source, date of isolation and underlying conditions among patients yielding C. tropicalis isolates are provided in S1 Table. The clinical specimens were collected after obtaining verbal consent from patients as part of routine patient care for the isolation of fungal pathogens and the data were analyzed anonymously. The consent procedure and the study were approved by the Ethics Committee of the Faculty of Medicine, Health Sciences Center, Kuwait University (Approval no. VDR/EC/2336 dated 2-6-2015). The phenotypic identity of the isolates was initially based on assimilation profiles on commercial Vitek 2 yeast identification system (bioMérieux, Marcy-l'Étoile, France) which was used according to manufacturer’s instructions. The isolates were sub-cultured on Sabouraud dextrose agar medium for molecular identification and MLST analyses.
DNA extraction and species-specific identification of C. tropicalis isolates
Genomic DNA was extracted from 1 ml of cell suspension in Sabouraud dextrose broth by using Gentra Puregene Yeast DNA extraction kit (Qiagen, Hilden, Germany) according to kit instructions or by the rapid method using Chelex-100 as described previously . Molecular identification was performed by PCR amplification of internally transcribed spacer (ITS) region of ribosomal DNA (rDNA) by designing and using two C. tropicalis-specific primers; CTROPF (5’-TTTATTTACAGTCAAACTTGAT-3’) and CTROPR (5’-TTAAATTCTTTCAAACAAACC-3’). PCR amplification and detection of amplicons by agarose gel electrophoresis was carried out as described previously [31, 32] except that CTROPF and CTROPR primers were used. DNA sequencing of the entire ITS region (including ITS-1-5.8S rRNA-ITS-2) of rDNA was also performed, as described previously [33, 34], for five selected isolates to confirm the results of species-specific PCR amplification. Basic local alignment search tool (BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&PAGE_TYPE=BlastHome) searches were carried out and >99% sequence identity with reference strain of C. tropicalis (ATCC 750) were used for species identification. The ITS region sequence data have been submitted to EMBL/GenBank databases under accession numbers LT837794 to LT837798.
Antifungal drug susceptibility testing
The susceptibility of C. tropicalis isolates against six antifungal drugs; amphotericin B, 5-flucytosine, fluconazole, voriconazole, caspofungin and micafungin was determined by using Vitek 2 AST system according to the manufacturer’s instructions (bioMérieux). The results were interpreted according to the revised interpretive susceptibility breakpoints as recommended by Clinical Laboratory Standards Institute (CLSI) . Quality control was ensured by testing C. albicans ATCC 90028, C. parapsilosis ATCC 22019 and C. tropicalis ATCC 750, as recommended by CLSI.
Fingerprinting of C. tropicalis isolates by MLST
All 63 C. tropicalis isolates were analyzed by using the MLST scheme based on PCR amplification and DNA sequencing of six housekeeping gene (ICL1, MDR1, SAPT2, SAPT4, XYR1 and ZWF1a) fragments as described by Tavanti et al. . However, we used new sets of primers for PCR amplification of each gene target and internal primers (to avoid any interference by primer-dimer artifacts) for more efficient sequencing of PCR amplicons . The sequences and other features of the primers used for MLST are listed in S2 Table.
The PCR amplification and cycling conditions for the six gene fragments were same as described previously  except that gene-specific amplification primers (listed in S2 Table) were used for each gene. The amplicons were purified and subjected to bi-directional sequencing as described previously [33, 34] except that gene-specific primers (listed in S2 Table) were used as sequencing primers. Each sequence chromatogram was reviewed for heterozygous (two equally strong and overlayed fluorescence peaks) nucleotide positions. The allelic profile (allele number) for each gene and allele combinations (diploid sequence type, DST) for the six loci for each isolate were assigned or new allele and new DST numbers were provided by the curator, Prof. Frank C. Odds of the C. tropicalis MLST database (http://pubmlst.org/ctropicalis/). The phylogenetic relationship of C. tropicalis isolates was also determined. Based on the allele number for the six loci for each isolate, a dendrogram was constructed with the clustering method, using unweighted pair group method with arithmetic averages (UPGMA) settings of BioNumerics v7.5 software (Applied Maths, Saint-Martens-Latem, Belgium). The isolates belonged to the same DST when they contained the same alleles for all six loci. A cluster was defined as a group of two or more patients infected with a C. tropicalis strain belonging to the same DST. The MLST data were further analyzed for clonal clusters by using the eBURST package. The genetic relationship between the 63 isolates from Kuwait with 804 isolates in the central data library of C. tropicalis MLST database as of January 2017 was also studied by using the minimum spanning tree of the BioNumerics software. The minimum spanning tree predicts putative relationships among the isolates and records the isolates as more closely related when five of six loci are identical.
Characteristics of patients yielding C. tropicalis isolates
We performed molecular genetic characterization and fingerprinting of 63 C. tropicalis isolates obtained from 54 patients. One isolate each was tested from 47 patients, two isolates each were obtained from five patients and three isolates each were tested from two patients. Multiple isolates from the same patient were from different anatomic sites. The majority (38 of 63, 60%) of the isolates were obtained from urine samples from patients with candiduria while only five isolates were obtained from bloodstream of candidemia patients.
The demographic details of the 54 patients yielding 63 C. tropicalis isolates were as follows. Most (48, 89%) patients were Kuwaiti nationals while six patients were non-Kuwaiti expatriate residents. The country of origin of non-Kuwaiti patients included Egypt (n = 2), Iran (n = 2), Bahrain (n = 1) and Pakistan (n = 1). The age range of the patients varied from 11 years to 97 years old. Nearly two-thirds (35 of 54, 65%) of the patients were >65 years of age and the ratio of male to female was nearly equal (28 males and 26 females). Four C. tropicalis isolates were obtained from four patients who were attending the clinic or out-patient department while the remaining 59 isolates were cultured from 50 hospitalized patients including 12 (22%) patients from an ICU, six patients from the emergency room, three patients from the dialysis unit and 29 patients from different wards in the hospital. Various underlying conditions for Candida infections were present in 49 of 54 patients (no information was available for four patients who attended the clinic or out-patient department and one patient who was admitted to the emergency room) and are summarized in Table 1. The most common underlying conditions were the presence of a urinary catheter, kidney disease and/or urinary tract infection in 29 patients, treatment with broad-spectrum antibiotics in 29 patients and diabetes mellitus in 24 patients. Other factors included prostate hyperplasia and/or cancer in 12 patients and gastro-intestinal bleeding, liver disease and/or abdominal surgery in 10 patients. The most common underlying condition among patients with candiduria included the presence of a urinary catheter, urinary obstruction (e.g. benign prostatic hyperplasia) and/or kidney disease and older (>65 years) age (Table 1).
Phenotypic and molecular identification of C. tropicalis isolates
Each isolate was subjected to identification by using Vitek 2 yeast identification system which identified all 63 isolates as C. tropicalis. For genotypic identification, the genomic DNA prepared from each isolate was subjected to PCR amplification of rDNA by using species-specific CTROPF and CTROPR primers. The species-specificity of the primers for C. tropicalis DNA was indicated by BLAST searches and was confirmed by lack of PCR amplification of rDNA with genomic DNA from common Candida species other than C. tropicalis, as expected. Only genomic DNA from reference C. tropicalis strain (ATCC 750) yielded an expected amplicon of 259 bp (S1 Fig). The genomic DNA from all 63 isolates yielded an amplicon of ~259 bp confirming the identification of all isolates as C. tropicalis. The DNA sequencing of the entire ITS region (including ITS-1-5.8S rRNA-ITS-2) of five selected isolates was also performed and showed variation at only one or two nucleotide positions (<1% difference) with the corresponding sequence from reference C. tropicalis strain (ATCC 750) further confirming the identification of all five isolates as C. tropicalis. The sequencing data also identified three ITS haplotypes among five C. tropicalis isolates (S2 Fig).
Phenotypic antifungal drug susceptibility testing of C. tropicalis isolates
The antifungal drug susceptibility testing (AST) of all 63 C. tropicalis isolates was performed against six (amphotericin B, 5-flucytosine, fluconazole, voriconazole, caspofungin and micafungin) antifungal drugs by using the Vitek 2 system and the results of AST are presented in S3 Table. All isolates were uniformly susceptible to amphotericin B, fluconazole, voriconazole, caspofungin and micafungin. The minimum inhibitory concentration (MIC) range for amphotericin B varied between 0.25 mg/L to 0.5 mg/L only. The MIC values for fluconazole, voriconazole, caspofungin and micafungin showed no variation among the isolates (S3 Table). Only one isolate (Kw45-15) with MIC value of 16 mg/L was resistant to 5-flucytosine while the remaining 62 isolates were susceptible to 5-flucytosine.
Genetic diversity of C. tropicalis isolates in Kuwait by MLST
The genetic diversity and population structure of C. tropicalis isolates in Kuwait was studied by MLST. All six gene fragments were successfully amplified, sequenced by using the corresponding gene-specific forward and reverse primers (S2 Table) and the DNA sequences were used to obtain the allelic profiles for each gene fragment and allele combinations to obtain DSTs from the C. tropicalis MLST database (http://pubmlst.org/ctropicalis/). A total of 88 cases of heterozygosity were detected in the six sequenced fragments and 144 polymorphic sites were identified, including 26 in ICL1, 36 in MDR1, 40 in SAPT2, 19 in SAPT4, 12 in XYR1 and 11 in ZWF1a. The highest typing efficiency (1.83 genotypes per polymorphism) was obtained with XYR1 while the lowest typing efficiency (0.27 genotypes per polymorphism) was obtained with SAPT2. Twenty-two new alleles were identified among C. tropicalis isolates from Kuwait during searches of the C. tropicalis MLST database (http://pubmlst.org/ctropicalis/).
The polymorphic alleles combined to form 59 DSTs among 63 C. tropicalis isolates from 54 patients. Of the 59 DSTs, only 5 DSTs (DST94, DST99, DST114, DST168 and DST238) for 6 isolates (DST238 was shared among two isolates) were present in the C. tropicalis MLST database while 54 DSTs (DST677 to DST731) for 57 isolates (DST678, DST681 and DST688 were shared among two isolates each) were new and were added to the C. tropicalis MLST database. Of the 54 new DSTs, 34 DSTs were generated by rearrangement of previously known alleles while the remaining 20 DSTs were formed due to the presence of a new allele for 1–3 genes. The allelic profile and the final DST for each isolate are shown in S1 Table.
The fingerprinting data further showed that multiple isolates from the same patient but recovered from different anatomic sites were genotypically different as they belonged to different DSTs. The seven urine C. tropicalis isolates obtained from seven candiduria patients were genotypically different than the isolates cultured from other clinical specimens of the same patient (Table 2). Six of seven candiduria patients were >65 years old while one patient was 60 years old and six of seven were male patients. Furthermore, bloodstream isolate from one patient belonged to a different DST than the isolates from urine and endotracheal aspirate from the same patient. Only two non-urine isolates from one patient and originating from the GIT (oral swab and anal swab) belonged to the same DST (Table 2). Interestingly, the two isolates from one patient (patient no. 18) differed at all six loci, two isolates from two patients (patient no. 9 and 14) differed at five loci, two isolates from one patient (patient no. 25) differed at four loci and two isolates from another patient (patient no. 30) differed at three loci. Multiple isolates from only two patients (patient no. 3 and 38) showed little or no variations (Table 2).
The genetic association between the DSTs of C. tropicalis isolates from Kuwait was determined by construction of an unrooted phylogenetic tree based on MLST data. The dendrogram (Fig 1) showed that most (55 of 63, 87%) of the isolates were dispersed as unrelated singletons belonging to a single unique DST while only four DSTs were shared, each among two isolates. Majority of the isolates differed at two or more loci. No obvious relationship was found between DSTs and specimen types or patient’s nationality. Among the four cluster DSTs (DST238, DST678, DST681 and DST688), DST688 actually involved two isolates from related clinical specimens from the same patient. The remaining three clusters included C. tropicalis isolates obtained from similar clinical specimens from two unrelated patients in each case. The clinical and epidemiological data from the patients yielding cluster isolates were compared to ascertain if the cluster isolates represented cross-transmission of infection and are presented in Table 3. The data showed that cluster isolates in each case were isolated at different time points which varied from >3 months to >5 months. Furthermore, the isolates were obtained from patients that were hospitalized in different wards in two of the three clusters.
Similarity is presented in percentages using the scale bar in the upper left corner. The columns from left to right include, isolate number, MLST-based diploid sequence type (DST), clinical specimen yielding the isolate, data of isolation, hospital ward/unit where the patients were housed and eBURST group. Repeat isolates from the same patient are indicated by alphabets within brackets and DSTs for cluster isolates are shown by an asterisk (*) before the DST.
The population structure of C. tropicalis isolates from Kuwait was further studied by determining genetic relationship between the 63 isolates from Kuwait with 804 isolates (as of January 2017) in the central data library of C. tropicalis MLST database by using the eBURST and minimal spanning tree algorithm of the BioNumerics software. The minimal spanning tree is depicted in Fig 2. Of the 59 DSTs detected among 63 isolates, 49 DSTs were grouped into seven groups (groups 1, 9, 20, 28, 30, 34 and 40), and 10 DSTs were identified as singletons. Interestingly, 43 of 49 (88%) clonal group isolates belonged to eBURST group 1 that also included most of the isolates from other geographical locations in the data base. Furthermore, most of the isolates from Kuwait clustered with isolates from several Asian (China, Taiwan and South Korea) countries while few isolates also clustered with C. tropicalis isolates from the United Kingdom and Brazil (Fig 2).
Each circle corresponds to a unique genotype, and lines between circles represent relative distance between isolates. The sizes of the circles correspond to the number of isolates of the same genotype (DST). Connecting lines correspond to the number of allele differences between genotypes, with a solid thick line connecting genotypes that differ in one locus, a solid thin line connecting genotypes that differ in two-three loci, a dashed line connecting genotypes that differ in four loci, and a dotted line connecting genotypes that differ in more than four loci.
This study is the first MLST analysis to characterize clinical C. tropicalis isolates from a Middle Eastern country and compared the patterns of variation with those in the MLST database representing isolates from other geographic regions. A total of 63 isolates obtained from 54 patients were analyzed. Consistent with earlier reports, most candiduria patients had several underlying conditions for Candida infections including age older than 65 years, urinary drainage devices, urinary obstruction (e.g. prostate hyperplasia) and/or kidney disease, prior use of broad-spectrum antibiotics and diabetes mellitus, however, unlike other studies, male patients outnumbered females [14–18]. Furthermore, all candidemia cases were associated with intravascular catheters.
All 63 isolates were phenotypically identified by Vitek 2 yeast identification system and genotypically by PCR amplification of rDNA by using novel C. tropicalis-specific (CTROPF and CTROPR) primers as C. tropicalis. The ITS sequencing data from five selected isolates identified three haplotypes showing genotypic heterogeneity among C. tropicalis isolates. Three ITS haplotypes were also identified among 48 C. tropicalis isolates while four haplotypes were identified for D1/D2 domains of rDNA in a recent study from Beijing, China . The ITS region sequences show greater variation than D1/D2 domain sequences within rDNA [37, 38]. It is, therefore, probable that sequencing of a larger number of C. tropicalis isolates from Kuwait and other geographical locations may identify additional ITS haplotypes as it was recently observed for clinical C. dubliniensis isolates [39–41].
The AST data obtained by using the Vitek 2 AST system which is considered comparable to the reference broth microdilution method  showed that all 63 C. tropicalis isolates were uniformly susceptible to amphotericin B, fluconazole, voriconazole, caspofungin and micafungin with MIC values showing little variation among the isolates. Thus, antifungal drug resistance was not a serious concern among C. tropicalis isolates at Al-Amiri Hospital in Kuwait. This could be due to relatively low antifungal consumption for prophylactic or empiric use as there are no hematology or oncology wards in our hospital. The findings are similar to two other studies from China and Taiwan which showed that resistance to fluconazole and other antifungal agents was rare in C. tropicalis isolates [26, 43]. However, they are contrary to several other reports documenting the presence of resistance to azoles and/or other antifungal agents among >20% of clinical C. tropicalis isolates from some geographical locations including some locations in China [44–50]. Resistance to antifungal agents in Candida spp. develops during therapy as a result of selective drug pressure [5, 6, 12, 42, 45, 48], however, one recent report has suggested that applications of triazole fungicides in indoor/outdoor environment may have selected resistant strains of C. tropicalis which were passed onto human hosts in Hainan, China, a scenario similar to the opportunistic human fungal pathogen Aspergillus fumigatus . Our data, however, do not support this scenario as triazole-resistant A. fumigatus have previously been isolated readily from both, environmental and clinical specimens [51–53] but azole resistance in Candida spp. has rarely been detected in Kuwait [30, 41, 54–56]. The data further showed that only one isolate (Kw45-15) was resistant to 5-flucytosine even though this drug is rarely used in Kuwait. Similar to our results, all C. tropicalis isolates from candidemia patients in the Spanish study were also susceptible to fluconazole and other antifungals while one isolate was resistant to 5-flucytosine . On the contrary, in a survey of fungemia cases due to C. tropicalis conducted in Paris, France, and among serial C. tropicalis isolates from ICU patients in Taipei, Taiwan, ~35% of the isolates were resistant to 5-flucytosine [43, 57].
The MLST identified 144 polymorphic sites with maximum number (n = 40) of sites obtained for SAPT2 among of 63 C. tropicalis isolates from Kuwait. Furthermore, the maximum typing efficiency (number of genotypes/polymorphic site) was obtained with XYR1 while the lowest typing efficiency was obtained with SAPT2. Previous studies from other geographical locations have reported variations in the number of polymorphic sites with different loci exhibiting maximum number of polymorphic sites as well as variations in typing efficiencies [23, 26, 45–47, 49]. These findings suggest genetic variations in C. tropicalis strains at different geographical locations. The MLST data further showed that C. tropicalis isolates from Kuwait contained abundant worldwide alleles for most loci but also exhibited novel genetic variations as 22 new alleles were also identified [http://pubmlst.org/ctropicalis/].
C. tropicalis isolates in Kuwait exhibited high genetic diversity as MLST identified 59 DSTs among 63 isolates including 54 new DSTs. All five (DST94, DST99, DST114, DST168 and DST238) previously described DSTs are rare and include only 2–5 isolates from China, Taiwan, UK, Colombia and Brazil. Although DST168, previously reported only from Taiwan, was found in Kuwait, DST164 which was also detected in Taiwan and was previously shown to be associated with 5-flucytosine resistance  was not detected in our study and the single 5-flucytosine-resistant isolate (Kw45-15) from Kuwait belonged to a new DST (DST719). Furthermore, DST238, which was shared between two isolates originating from vaginal and percutaneous endoscopic gastrostomy specimens in Kuwait, has previously been described for two bloodstream isolates from Brazil . Our data reinforce previous observations suggesting lack of association between different DSTs with antifungal resistance, specimen type or geographical location and support both shared and unique features among geographic populations of C. tropicalis [23, 26, 46, 49].
Among the seven patients yielding multiple isolates from different anatomic sites at the same or nearly same time, isolates from only two patients (patient no. 3 and 38) belonged to identical or highly related (with five or all 6 identical loci) DSTs while multiple isolates from the remaining five patients belonged to unrelated (with 3 or 4 different loci) or highly unrelated (with 5 or all 6 different loci) DSTs indicating microvariation as well as macrovariation in the nucleotide polymorphisms of the six loci. Other MLST studies involving multiple isolates from individual patients have also reported that some patients maintain the same C. tropicalis clone while isolates in other patients either undergo microvariation in one or two genes yielding related DSTs or macrovariation in nearly all six genes yielding unrelated and different DSTs [23, 43, 46, 47]. The MLST data from Brazil also showed that C. tropicalis isolates from the catheter were genetically different than the bloodstream isolate(s) in eight of nine patients indicating that different clonal populations co-exist within the same host . Taken together, these findings suggest that C. tropicalis isolates undergo genetic alterations in the six genes used for MLST under the application of host and other (such as antifungal) stresses. This is in contrast to C. albicans where sequential/multiple clinical isolates from various anatomical sites of the same patient have been shown by MLST analyses to be genetically identical or highly similar [56, 58–62].
The phylogenetic tree based on MLST data showed that most (55 of 63, 87%) of the isolates were unique strains while only four DSTs were shared, each among two isolates. The clinical and epidemiological data from the patients yielding cluster isolates showed that cluster isolates in each case were isolated at different time points. Furthermore, the isolates were obtained from patients hospitalized in different wards in two of the three clusters. These findings suggest that intrahospital transmission of C. tropicalis does not occur or occurs rarely among hospitalized patients in Kuwait. Intrahospital transmission of C. albicans was also not found in a recent study involving candidemia patients in Kuwait .
The data presented in this study have shown that most C. tropicalis strains were isolated from patients whose mean age was >65 years. Common underlying conditions detected among patients yielding C. tropicalis isolates included urinary catheter, treatment with broad-spectrum antibiotics, diabetes mellitus and RT/GIT abnormalities. Most candiduria cases had urinary catheter, ureteric stent or suprapubic catheters. All isolates were susceptible to five of six antifungal drugs and only one isolate was resistant to 5-flucytosine. MLST identified 59 DSTs including 54 newly-identified DSTs. C. tropicalis isolates from multiple sites of same patient usually belonged to different DSTs. Interestingly, 56 of 57 isolates from 48 patients belonged to unique genotypes. Our data show diverse origins of C. tropicalis infections in Kuwait as most isolates were unique strains, however, microvariation and macrovariation were also noted among C. tropicalis isolates recovered from the same patients. Only six isolates from six patients belonged to three DSTs (clusters), however, C. tropicalis strains in each cluster were isolated >3 months apart. There was no obvious correlation between cluster isolates with respect to the time of isolation and/or hospital ward of their origin. The study has also provided information on MLST-based DSTs found among clinical C. tropicalis isolates for the first time from a Middle Eastern country. New DSTs have been added to the growing list in the MLST central database that will be useful for further studies on genetic relationship and global molecular epidemiology of C. tropicalis strains.
S1 Table. Source of isolation, clinical characteristics and MLST data for 63 C. tropicalis isolates obtained from 54 patients analyzed in this study.
S2 Table. Salient features of various oligonucleotide primers used during MLST of C. tropicalis isolates in this study.
S3 Table. Antifungal drug susceptibility testing data and the minimum inhibitory concentration (MIC) range, MIC50 and MIC90 values for 63 C. tropicalis isolates.
S1 Fig. Agarose gel of PCR products using C. tropicalis-specific (CTROPF and CTROPR) primers and genomic DNA from reference strains of C. albicans (Lane CA), C. dubliniensis (Lane CD), C. tropicalis (Lane CT), C. viswanathii (Lane CV), C. parapsilosis (Lane CP), C. orthopsilosis (Lane CO), L. elongisporus (Lane LE), C. glabrata (Lane CG), C. nivariensis (Lane CN) and C. bracarensis (Lane CB).
- 1. Borges M, Zaragoza R. Critical overview of clinical guidelines relating to invasive fungal infections. Int J Antimicrob Agents 2008; 32 (Suppl 2): S155–S159.
- 2. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med 2012; 4: 165rv13. pmid:23253612
- 3. Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect 2014; 20 (Suppl 6): 5–10.
- 4. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–317. pmid:15306996
- 5. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008; 29: 996–1011.
- 6. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 2010; 48: 1366–1377. pmid:20164282
- 7. Muñoz P, Giannella M, Fanciulli C, Guinea J, Valerio M, Rojas L, et al. Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect 2011; 17: 1538–1545. pmid:20718804
- 8. Chen CY, Chen YC, Tang JL, Yao M, Huang SY, Tsai W, et al. Hepatospleenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis. Ann Hematol 2003; 82: 93–97. pmid:12601487
- 9. Lai HP, Chen YC, Chang LY, Lu CY, Lee CY, Lin KH, et al. Invasive fungal infection in children with persistent febrile neutropenia. J Formos Med Assoc 2005; 104: 174–179. pmid:15818431
- 10. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006; 44: 2816–2823. pmid:16891497
- 11. Negri M, Silva S, Henriques M, Oliveira R. Insights into Candida tropicalis nosocomial infections and virulence factors. Eur J Clin Microbiol Infect Dis 2012; 31: 399–1412.
- 12. Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Antimicrob Agents Chemother 1995; 39: 40–44. pmid:7695326
- 13. Wang JL, Chang SC, Hsueh PR, Chen YC. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002. J Microbiol Immunol Infect 2004; 37: 236–241. pmid:15340652
- 14. Kaufmann CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin N Am 2014; 28: 61–74.
- 15. Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J, Co-operative Group of the European Study Group on Nosocomial Infections. A European perspective on nosocomial urinary tract infections. I. Report on the microbiology workload, etiology, and antimicrobial susceptibility (ESGNI-003 study). Clin Microbiol Infect 2001; 7: 523–531. pmid:11683792
- 16. Alvarez-Lerma F, Nolla-Salas J, Leon C, León C, Palomar M, Jordá R, Carrasco N, et al. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med 2003; 29: 1069–1076. pmid:12756441
- 17. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis 2000; 30: 14–18. pmid:10619726
- 18. Kobayashi CC, de Fernandes OF, Miranda KC, de Sousa ED, Silva Mdo R. Candiduria in hospital patients: a prospective study. Mycopathologia 2004; 158: 49–52. pmid:15487320
- 19. Binelli CA, Moretti ML, Assis RS, Sauaia N, Menezes PR, Ribeiro E, et al. Investigation of the possible association between nosocomial candiduria and candidemia. Clin Microbiol Infect 2006; 12: 538–543. pmid:16700702
- 20. Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY; CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management, and outcome. Intensive Care Med 2008; 34: 292–299. pmid:17909746
- 21. Asmundsdóttir LR, Erlendsdóttir H, Haraldsson G, Guo H, Xu J, Gottfredsson M. Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clin Infect Dis 2008; 47: e17–e24. pmid:18549311
- 22. Suleyman G, Alangaden GJ. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infect Dis Clin North Am 2016; 30: 1023–1052. pmid:27816138
- 23. Tavanti A, Davidson AD, Johnson EM, Maiden MC, Shaw DJ, Gow NA, et al. Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol 2005; 43: 5593–5600. pmid:16272492
- 24. Wu Y, Zhou HJ, Che J, Li WG, Bian FN, Yu SB, et al. Multilocus microsatellite markers for molecular typing of Candida tropicalis isolates. BMC Microbiol 2014; 14: 245. pmid:25410579
- 25. Fan X, Xiao M, Liu P, Chen S, Kong F, Wang H, et al. Novel polymorphic multilocus microsatellite markers to distinguish Candida tropicalis isolates. PLoS One 2016; 11: e0166156. pmid:27820850
- 26. Wu Y, Zhou H, Wang J, Li L, Li W, Cui Z, et al. Analysis of the clonality of Candida tropicalis strains from a general hospital in Beijing using multilocus sequence typing. PLoS One 2012; 7: e47767. pmid:23152759
- 27. Fan X, Xiao M, Wang H, Zhang L, Kong F, Lu J, et al. Multilocus sequence typing indicates diverse origins of invasive Candida tropicalis isolates in China. Chin Med J (Engl) 2014; 127: 4226–4234.
- 28. Rho J, Shin JH, Song JW, Park MR, Kee SJ, Jang SJ, et al. Molecular investigation of two consecutive nosocomial clusters of Candida tropicalis candiduria using pulsed-field gel electrophoresis. J Microbiol 2004; 42: 80–86. pmid:15357299
- 29. Jang SJ, Han HL, Lee SH, Ryu SY, Chaulagain BP, Moon YL, et al. PFGE-based epidemiological study of an outbreak of Candida tropicalis candiduria: the importance of medical waste as a reservoir of nosocomial infection. Jpn J Infect Dis 2005; 58: 263–267. pmid:16249617
- 30. Asadzadeh M, Ahmad S, Hagen F, Meis JF, Al-Sweih N, Khan Z. Simple, low-cost detection of Candida parapsilosis complex isolates and molecular fingerprinting of Candida orthopsilosis strains in Kuwait by ITS region sequencing and amplified fragment length polymorphism analysis. PLoS One 2015; 10: e0142880. pmid:26580965
- 31. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40: 2483–2489. pmid:12089267
- 32. Ahmad S, Mustafa AS, Khan Z, Al-Rifayi A, Khan ZU. PCR-enzyme immunoassay of rDNA in the diagnosis of candidemia and comparison of amplicon detection by agarose gel electrophoresis. Int. J Med Microbiol. 2004; 294: 45–51. pmid:15293453
- 33. Khan ZU, Ahmad S, Mokaddas E, Chandy R, Cano J, Guarro J. Actinomucor elegans var. kuwaitiensis isolated from the wound of a diabetic patient. Antonie van Leeuwoenhoek 2008; 94: 343–352.
- 34. Khan ZU, Ahmad S, Hagen F, Fell JW, Kowshik T, Chandy R, et al. Cryptococcus randhawai sp. nov., a novel anamorphic basidiomycetous yeast isolated from tree trunk hollow of Ficus religiosa (peepal tree) from New Delhi, India. Antonie van Leeuwoenhoek Int J Gen Mol Microbiol 2010; 97: 253–259.
- 35. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement, M27-S4. Wayne, PA, USA. 2012.
- 36. Leonard JT, Grace MB, Buzard GS, Mullen MJ, Barbagallo CB. Preparation of PCR products for DNA sequencing. BioTechniques 1998; 24: 314–317. pmid:9494735
- 37. Kurtzman CP, Robnett CJ. Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA sequences. Antonie van Leeuwenhoek 1998; 73: 331–371. pmid:9850420
- 38. Hou X, Xiao M, Chen SC, Wang H, Zhang L, Fan X, et al. Sequencer-based capillary gel electrophoresis (SCGE) targeting the rDNA internal transcribed spacer (ITS) regions for accurate identification of clinically important yeast species. PLoS One 2016; 11: e0154385. pmid:27105313
- 39. Gee SF, Joly S, Soll DR, Meis JF, Verweij PE, Polacheck I, et al. Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J Clin Microbiol 2002; 40: 556–574. pmid:11825972
- 40. Ahmad S, Khan ZU, Joseph L, Asadzadeh M, Theyyathel A. Genotypic heterogeneity and molecular basis of 5-flucytosine resistance among Candida dubliniensis isolates recovered from clinical specimens in Kuwait. Med Mycol 2012; 50: 244–251. pmid:21895416
- 41. Asadzadeh M, Ahmad S, Al-Sweih N, Khan ZU. Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait. PLOS One 2017; 12: e0175269. pmid:28380072
- 42. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values. Diagn Microbiol Infect Dis 2013; 77: 37–40. pmid:23870164
- 43. Chen KW, Chen YC, Lin YH, Chou HH, Li SY. The molecular epidemiology of serial Candida tropicalis isolates from ICU patients as revealed by multilocus sequence typing and pulsed-field gel electrophoresis. Infect Genet Evol 2009; 9: 912–920. pmid:19540937
- 44. Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, et al. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. J Antimicrob Chemother 2015; 70: 802–810. pmid:25473027
- 45. Fan X, Xiao M, Liao K, Kudinha T, Wang H, Zhang L, et al. Notable increasing trend in azole non-susceptible Candida tropicalis causing invasive candidiasis in China (August 2009 to July 2014): molecular epidemiology and clinical azole consumption. Front Microbiol 2017; 8: 464. pmid:28382028
- 46. Magri MM, Gomes-Gouvêa MS, de Freitas VL, Motta AL, Moretti ML, Shikanai-Yasuda MA. Multilocus sequence typing of Candida tropicalis shows the presence of different clonal clusters and fluconazole susceptibility profiles in sequential isolates from candidemia patients in Sao Paulo, Brazil. J Clin Microbiol 2013; 51: 268–277. pmid:23152555
- 47. Wang Y, Shi C, Liu JY, Li WJ, Zhao Y, Xiang MJ. Multilocus sequence typing of Candida tropicalis shows clonal cluster enrichment in azole-resistant isolates from patients in Shanghai, China. Infect Genet Evol 2016; 44: 418–424. pmid:27456280
- 48. Castanheira M, Messer SA, Rhomberg PR, Pfaller MA. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013). Diagn Microbiol Infect Dis 2016; 85: 200–204. pmid:27061369
- 49. Wu JY, Guo H, Wang HM, Yi GH, Zhou LM, He XW, et al. Multilocus sequence analyses reveal extensive diversity and multiple origins of fluconazole resistance in Candida tropicalis from tropical China. Sci Rep 2017; 7: 42537. pmid:28186162
- 50. Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother 2017; 72: 1103–1108. pmid:28364558
- 51. Ahmad S, Khan Z, Hagen F, Meis JF. Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait. Environ Res 2014; 133: 20–26. pmid:24906064
- 52. Ahmad S, Khan Z, Hagen F, Meis JF. Simple, low-cost molecular assays for TR34/L98H mutations in the cyp51A gene for rapid detection of triazole-resistant Aspergillus fumigatus isolates. J Clin Microbiol 2014; 52:2223–2227. pmid:24719446
- 53. Ahmad S, Joseph L, Hagen F, Meis JF, Khan Z. Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures. J Antimicrob Chemother 2015; 70: 412–415. pmid:25326091
- 54. Mokaddas EM, Al-Sweih NA, Khan ZU. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. J Med Microbiol 2007; 56: 255–259. pmid:17244809
- 55. Al-Sweih N, Khan Z, Khan S, Devarajan LV. Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility. Mycoses 2009; 52: 518–223. pmid:18983425
- 56. Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. Molecular fingerprinting studies do not support intrahospital transmission of Candida albicans among candidemia patients in Kuwait. Front Microbiol 2017; 8: 247. pmid:28270801
- 57. Desnos-Ollivier M, Bretagne S, Bernède C, Robert V, Raoux D, Chachaty E, et al. Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, France. Emerg Infect Dis 2008; 14: 557–565. pmid:18394272
- 58. Tavanti A, Davidson AD, Fordyce MJ, Gow NA, Maiden MC, Odds FC. Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J Clin Microbiol 2005; 43:5601–561. pmid:16272493
- 59. Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY; CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 2008; 34: 292–299. pmid:17909746
- 60. Cliff PR, Sandoe JA, Heritage J, Barton RC. Use of multilocus sequence typing for the investigation of colonisation by Candida albicans in intensive care unit patients. J Hosp Infect 2008; 69: 24–32. pmid:18396349
- 61. Afsarian MH, Badali H, Boekhout T, Shokohi T, Katiraee F. Multilocus sequence typing of Candida albicans isolates from a burn intensive care unit in Iran. J Med Microbiol 2015; 64: 248–253. pmid:25596113
- 62. Moorhouse AJ, Rennison C, Raza M, Lilic D, Gow NA. Clonal strain persistence of Candida albicans isolates from chronic mucocutaneous candidiasis patients. PLoS One 2016; 11: e0145888. pmid:26849050